The FCA Insider

Insights and updates on False Claims Act Litigation

Tag Archives: pharmaceuticals

OIG, Regulatory November 20, 2020

OIG Issues Special Fraud Alert That Challenges Industry Norms Regarding Speakers Programs

On Nov. 16, 2020, the Office of Inspector General (OIG) of the U.S. Department of Health and Human Services issued a special fraud alert addressing fraud and abuse concerns with speakers programs conducted by pharmaceutical and medical device companies. While the fraud alert reiterates historical OIG and Department of Justice (DOJ) concerns regarding speakers programs, it… Continue Reading

David Pivnick's practice is focused on complex commercial litigation with an emphasis on healthcare litigation. READ MORE

Brett Barnett's practice is focused on complex commercial litigation with an emphasis on healthcare litigation. READ MORE

Timothy Fry helps clients navigate the thorny compliance and regulatory issues prevalent in the healthcare industry. READ MORE

Michael J. Podberesky is a former federal prosecutor in the U.S. Department of Justice’s Civil Fraud Section.
READ MORE

At McGuireWoods, we deliver quality work, personalized service and exceptional value. We use technology to provide efficient legal solutions and employ a diverse workforce to bring real-world and innovative perspectives to meeting our clients’ needs. With 1,100 lawyers and 21 strategically located offices worldwide, McGuireWoods uses client-focused teams to serve public, private, government and nonprofit clients from many industries, including automotive, energy resources, healthcare, technology and transportation.

We use cookies to enhance your experience of our website. By continuing to use this website, you agree to the use of these cookies. For more information and to learn how you can change your cookie settings, please see our policy.

Agree